Genprex

News

Genprex to Present at the 2021 Virtual Cell & Gene Meeting on the Mediterranean

Company overview to highlight novel gene therapies for cancer and diabetes

Read More

Taking gene therapy to the masses with innovations in diabetes, Alzheimer’s and more

What will it take to transition gene therapy from a treatment for diseases that only affect a few hundred thousand people worldwide to Type 1 diabetes, which is estimated to affect more than 45 million?

Read More

Genprex Announces Preclinical Data for TUSC2 Immunogene Therapy in Non-Small Cell Lung Cancer to Be Featured in Two Presentations at the 2021 American Association for Cancer Research Annual Meeting

Two Featured Presentations will Highlight Potential of TUSC2 Immunogene Therapy to Enhance Chemo-Immune Combination Treatments and Overcome Resistance to Osimertinib

Read More

Genprex to Present at the Spring 2021 Oncology Investor Conference on March 29

Investor presentation to highlight novel gene therapies for cancer and diabetes

Read More

Genprex to Participate in Upcoming March Investor Conferences

Investor presentations to highlight novel gene therapies for cancer and diabetes

Read More

2 Austin medical companies expect to raise millions with stock offerings

Two Austin-based companies involved in medial research say they expect to raise millions of dollars with stock offerings this week.

Read More

Genprex, Inc. Announces $25 Million Registered Direct Offering Priced At-The-Market Under NASDAQ Rules, Without Warrants

Genprex has entered into securities purchase agreements with two healthcare-dedicated institutional investors for the purchase and sale of 4,000,000 shares of its common stock at a purchase price of $6.25 per share in a registered direct offering priced at-the-market under Nasdaq rules.

Read More

Genprex Announces Formation of Clinical Advisory Board

World reknowned medical and clinical experts to guide Genprex’ novel gene therapy clinical development programs in cancer and diabetes, including its two upcoming clinical trials in lung cancer

Read More

Genprex Recognizes World Cancer Day

Joins Global Movement to Raise Awareness and Reduce the Burden of Cancer Worldwide

Read More

Genprex is on the Cutting Edge of Lung Cancer Treatment Development

Mr. Redman provides his reaction to a recent article in ONCOLOGY® and discusses how Genprex is harnessing breakthroughs in lung cancer treatment.

Read More